NCT06045156View on ClinicalTrials.gov

Early Tirofiban Administration After Intravenous Thrombolysis in Acute Ischemic Stroke

NARecruitingINTERVENTIONAL
Enrollment

1,084

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

January 30, 2026

Study Completion Date

December 30, 2026

Conditions
Acute Ischemic Stroke
Interventions
DRUG

Tirofiban

Tirofiban is a selective glycoproteinⅡb/Ⅲa receptor inhibitor, which inhibits platelet aggregation and thrombi formation

DRUG

Tirofiban simulant

Tirofiban simulant is placebo packed the same style as tirofiban

Trial Locations (1)

130000

RECRUITING

The first hospital of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER